nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—TYMS—colon cancer	0.367	0.798	CbGaD
Trimethoprim—TYMS—Capecitabine—colon cancer	0.171	0.364	CbGbCtD
Trimethoprim—TYMS—Fluorouracil—colon cancer	0.101	0.216	CbGbCtD
Trimethoprim—ABCB1—colon cancer	0.0929	0.202	CbGaD
Trimethoprim—DHFR—Methotrexate—colon cancer	0.0803	0.171	CbGbCtD
Trimethoprim—TYMS—Methotrexate—colon cancer	0.0559	0.119	CbGbCtD
Trimethoprim—CYP2C9—Capecitabine—colon cancer	0.0135	0.0288	CbGbCtD
Trimethoprim—CYP2C8—Fluorouracil—colon cancer	0.0115	0.0245	CbGbCtD
Trimethoprim—ABCB1—Irinotecan—colon cancer	0.00812	0.0173	CbGbCtD
Trimethoprim—CYP2C9—Fluorouracil—colon cancer	0.00803	0.0171	CbGbCtD
Trimethoprim—ABCB1—Vincristine—colon cancer	0.00709	0.0151	CbGbCtD
Trimethoprim—CYP3A4—Irinotecan—colon cancer	0.00486	0.0103	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—colon cancer	0.0043	0.00913	CbGbCtD
Trimethoprim—CYP3A4—Vincristine—colon cancer	0.00425	0.00904	CbGbCtD
Trimethoprim—TYMS—Vinorelbine—Vincristine—colon cancer	0.00098	0.593	CbGdCrCtD
Trimethoprim—DHFR—embryo—colon cancer	0.000813	0.0787	CbGeAlD
Trimethoprim—TYMS—Vinblastine—Vincristine—colon cancer	0.000674	0.407	CbGdCrCtD
Trimethoprim—TYMS—smooth muscle tissue—colon cancer	0.000646	0.0625	CbGeAlD
Trimethoprim—DHFR—renal system—colon cancer	0.000615	0.0596	CbGeAlD
Trimethoprim—DHFR—G1/S-Specific Transcription—TYMS—colon cancer	0.000532	0.0512	CbGpPWpGaD
Trimethoprim—TYMS—lymphoid tissue—colon cancer	0.000516	0.05	CbGeAlD
Trimethoprim—DHFR—lymphoid tissue—colon cancer	0.000511	0.0495	CbGeAlD
Trimethoprim—TYMS—digestive system—colon cancer	0.00051	0.0494	CbGeAlD
Trimethoprim—DHFR—digestive system—colon cancer	0.000505	0.0489	CbGeAlD
Trimethoprim—TYMS—bone marrow—colon cancer	0.00047	0.0455	CbGeAlD
Trimethoprim—DHFR—bone marrow—colon cancer	0.000465	0.0451	CbGeAlD
Trimethoprim—TYMS—vagina—colon cancer	0.00045	0.0436	CbGeAlD
Trimethoprim—DHFR—vagina—colon cancer	0.000446	0.0432	CbGeAlD
Trimethoprim—TYMS—liver—colon cancer	0.00038	0.0368	CbGeAlD
Trimethoprim—DHFR—liver—colon cancer	0.000376	0.0364	CbGeAlD
Trimethoprim—DHFR—One Carbon Metabolism—TYMS—colon cancer	0.000357	0.0344	CbGpPWpGaD
Trimethoprim—ABCB1—blood vessel—colon cancer	0.000324	0.0314	CbGeAlD
Trimethoprim—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—colon cancer	0.000321	0.0309	CbGpPWpGaD
Trimethoprim—DHFR—Fluoropyrimidine Activity—TYMS—colon cancer	0.000313	0.0301	CbGpPWpGaD
Trimethoprim—DHFR—E2F mediated regulation of DNA replication—TYMS—colon cancer	0.000313	0.0301	CbGpPWpGaD
Trimethoprim—CYP2C8—renal system—colon cancer	0.000305	0.0296	CbGeAlD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000302	0.0291	CbGpPWpGaD
Trimethoprim—TYMS—lymph node—colon cancer	0.000291	0.0282	CbGeAlD
Trimethoprim—DHFR—lymph node—colon cancer	0.000288	0.0279	CbGeAlD
Trimethoprim—Eosinophilia—Fluorouracil—colon cancer	0.000279	0.00581	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Vincristine—colon cancer	0.000275	0.00574	CcSEcCtD
Trimethoprim—Neutropenia—Irinotecan—colon cancer	0.000275	0.00573	CcSEcCtD
Trimethoprim—Pneumonia—Vincristine—colon cancer	0.000271	0.00564	CcSEcCtD
Trimethoprim—Depression—Vincristine—colon cancer	0.000268	0.00559	CcSEcCtD
Trimethoprim—Pancytopenia—Fluorouracil—colon cancer	0.000267	0.00557	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000264	0.0254	CbGpPWpGaD
Trimethoprim—Neuropathy peripheral—Vincristine—colon cancer	0.000264	0.0055	CcSEcCtD
Trimethoprim—Pneumonia—Irinotecan—colon cancer	0.000264	0.0055	CcSEcCtD
Trimethoprim—Stomatitis—Vincristine—colon cancer	0.000262	0.00547	CcSEcCtD
Trimethoprim—Photosensitivity—Capecitabine—colon cancer	0.000259	0.0054	CcSEcCtD
Trimethoprim—Renal failure—Irinotecan—colon cancer	0.000258	0.00537	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Fluorouracil—colon cancer	0.000257	0.00536	CcSEcCtD
Trimethoprim—Stomatitis—Irinotecan—colon cancer	0.000255	0.00533	CcSEcCtD
Trimethoprim—Vascular purpura—Capecitabine—colon cancer	0.000254	0.00531	CcSEcCtD
Trimethoprim—Glossitis—Methotrexate—colon cancer	0.000253	0.00528	CcSEcCtD
Trimethoprim—Pneumonia—Fluorouracil—colon cancer	0.000252	0.00526	CcSEcCtD
Trimethoprim—Haemolytic anaemia—Capecitabine—colon cancer	0.000252	0.00526	CcSEcCtD
Trimethoprim—Infestation—Fluorouracil—colon cancer	0.000251	0.00523	CcSEcCtD
Trimethoprim—Infestation NOS—Fluorouracil—colon cancer	0.000251	0.00523	CcSEcCtD
Trimethoprim—Hepatic enzyme increased—Methotrexate—colon cancer	0.000247	0.00515	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Fluorouracil—colon cancer	0.000246	0.00513	CcSEcCtD
Trimethoprim—Stomatitis—Fluorouracil—colon cancer	0.000245	0.0051	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Capecitabine—colon cancer	0.000241	0.00503	CcSEcCtD
Trimethoprim—Hallucination—Vincristine—colon cancer	0.00024	0.00501	CcSEcCtD
Trimethoprim—Renal impairment—Capecitabine—colon cancer	0.000239	0.00499	CcSEcCtD
Trimethoprim—Urinary tract disorder—Vincristine—colon cancer	0.000239	0.00497	CcSEcCtD
Trimethoprim—Dermatitis bullous—Capecitabine—colon cancer	0.000238	0.00497	CcSEcCtD
Trimethoprim—Connective tissue disorder—Vincristine—colon cancer	0.000237	0.00495	CcSEcCtD
Trimethoprim—Urethral disorder—Vincristine—colon cancer	0.000237	0.00494	CcSEcCtD
Trimethoprim—Epistaxis—Fluorouracil—colon cancer	0.000237	0.00494	CcSEcCtD
Trimethoprim—Purpura—Capecitabine—colon cancer	0.000236	0.00492	CcSEcCtD
Trimethoprim—Agranulocytosis—Fluorouracil—colon cancer	0.000234	0.00488	CcSEcCtD
Trimethoprim—Lethargy—Capecitabine—colon cancer	0.000232	0.00484	CcSEcCtD
Trimethoprim—Connective tissue disorder—Irinotecan—colon cancer	0.000231	0.00482	CcSEcCtD
Trimethoprim—Hyponatraemia—Capecitabine—colon cancer	0.000228	0.00477	CcSEcCtD
Trimethoprim—CYP2C9—digestive system—colon cancer	0.000223	0.0216	CbGeAlD
Trimethoprim—CYP2C8—vagina—colon cancer	0.000221	0.0214	CbGeAlD
Trimethoprim—Aplastic anaemia—Methotrexate—colon cancer	0.000219	0.00457	CcSEcCtD
Trimethoprim—Mediastinal disorder—Vincristine—colon cancer	0.000218	0.00454	CcSEcCtD
Trimethoprim—Ataxia—Capecitabine—colon cancer	0.000214	0.00446	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.000214	0.0206	CbGpPWpGaD
Trimethoprim—Immune system disorder—Irinotecan—colon cancer	0.000212	0.00443	CcSEcCtD
Trimethoprim—Mediastinal disorder—Irinotecan—colon cancer	0.000212	0.00442	CcSEcCtD
Trimethoprim—Mental disorder—Vincristine—colon cancer	0.000212	0.00441	CcSEcCtD
Trimethoprim—CYP3A4—renal system—colon cancer	0.000207	0.02	CbGeAlD
Trimethoprim—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000205	0.00427	CcSEcCtD
Trimethoprim—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—colon cancer	0.000197	0.019	CbGpPWpGaD
Trimethoprim—Erythema—Fluorouracil—colon cancer	0.000196	0.00409	CcSEcCtD
Trimethoprim—ABCB1—embryo—colon cancer	0.000193	0.0187	CbGeAlD
Trimethoprim—Agitation—Vincristine—colon cancer	0.000193	0.00403	CcSEcCtD
Trimethoprim—Photosensitivity—Methotrexate—colon cancer	0.000193	0.00402	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00019	0.0183	CbGpPWpGaD
Trimethoprim—Vertigo—Vincristine—colon cancer	0.000189	0.00394	CcSEcCtD
Trimethoprim—Leukopenia—Vincristine—colon cancer	0.000188	0.00393	CcSEcCtD
Trimethoprim—Pancytopenia—Capecitabine—colon cancer	0.000187	0.0039	CcSEcCtD
Trimethoprim—CYP2C8—liver—colon cancer	0.000187	0.0181	CbGeAlD
Trimethoprim—Vertigo—Irinotecan—colon cancer	0.000184	0.00384	CcSEcCtD
Trimethoprim—Neutropenia—Capecitabine—colon cancer	0.000184	0.00384	CcSEcCtD
Trimethoprim—Syncope—Irinotecan—colon cancer	0.000184	0.00383	CcSEcCtD
Trimethoprim—Leukopenia—Irinotecan—colon cancer	0.000183	0.00382	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—TOP1—colon cancer	0.000183	0.0176	CbGpPWpGaD
Trimethoprim—Convulsion—Vincristine—colon cancer	0.000182	0.0038	CcSEcCtD
Trimethoprim—Loss of consciousness—Irinotecan—colon cancer	0.00018	0.00375	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Methotrexate—colon cancer	0.00018	0.00374	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Capecitabine—colon cancer	0.00018	0.00374	CcSEcCtD
Trimethoprim—Myalgia—Vincristine—colon cancer	0.000179	0.00373	CcSEcCtD
Trimethoprim—Cough—Irinotecan—colon cancer	0.000179	0.00373	CcSEcCtD
Trimethoprim—Pneumonia—Capecitabine—colon cancer	0.000176	0.00368	CcSEcCtD
Trimethoprim—Leukopenia—Fluorouracil—colon cancer	0.000176	0.00366	CcSEcCtD
Trimethoprim—Infestation NOS—Capecitabine—colon cancer	0.000175	0.00366	CcSEcCtD
Trimethoprim—Infestation—Capecitabine—colon cancer	0.000175	0.00366	CcSEcCtD
Trimethoprim—Depression—Capecitabine—colon cancer	0.000175	0.00365	CcSEcCtD
Trimethoprim—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000174	0.0167	CbGpPWpGaD
Trimethoprim—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000174	0.00363	CcSEcCtD
Trimethoprim—Lethargy—Methotrexate—colon cancer	0.000173	0.00361	CcSEcCtD
Trimethoprim—Renal failure—Capecitabine—colon cancer	0.000172	0.0036	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Capecitabine—colon cancer	0.000172	0.00359	CcSEcCtD
Trimethoprim—Anaphylactic shock—Vincristine—colon cancer	0.000172	0.00358	CcSEcCtD
Trimethoprim—Stomatitis—Capecitabine—colon cancer	0.000171	0.00356	CcSEcCtD
Trimethoprim—Convulsion—Fluorouracil—colon cancer	0.00017	0.00354	CcSEcCtD
Trimethoprim—CYP3A4—digestive system—colon cancer	0.00017	0.0164	CbGeAlD
Trimethoprim—Confusional state—Irinotecan—colon cancer	0.000168	0.00351	CcSEcCtD
Trimethoprim—Nervous system disorder—Vincristine—colon cancer	0.000168	0.00351	CcSEcCtD
Trimethoprim—Thrombocytopenia—Vincristine—colon cancer	0.000168	0.0035	CcSEcCtD
Trimethoprim—Haematuria—Capecitabine—colon cancer	0.000167	0.00349	CcSEcCtD
Trimethoprim—Anaphylactic shock—Irinotecan—colon cancer	0.000167	0.00349	CcSEcCtD
Trimethoprim—Myalgia—Fluorouracil—colon cancer	0.000167	0.00348	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—TYMS—colon cancer	0.000166	0.016	CbGpPWpGaD
Trimethoprim—Hepatobiliary disease—Capecitabine—colon cancer	0.000166	0.00346	CcSEcCtD
Trimethoprim—CYP2C9—liver—colon cancer	0.000166	0.0161	CbGeAlD
Trimethoprim—Epistaxis—Capecitabine—colon cancer	0.000165	0.00345	CcSEcCtD
Trimethoprim—Shock—Irinotecan—colon cancer	0.000164	0.00343	CcSEcCtD
Trimethoprim—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000164	0.0158	CbGpPWpGaD
Trimethoprim—Nervous system disorder—Irinotecan—colon cancer	0.000164	0.00342	CcSEcCtD
Trimethoprim—Agranulocytosis—Capecitabine—colon cancer	0.000164	0.00341	CcSEcCtD
Trimethoprim—Thrombocytopenia—Irinotecan—colon cancer	0.000164	0.00341	CcSEcCtD
Trimethoprim—Anorexia—Vincristine—colon cancer	0.000164	0.00341	CcSEcCtD
Trimethoprim—Confusional state—Fluorouracil—colon cancer	0.000161	0.00337	CcSEcCtD
Trimethoprim—Anaphylactic shock—Fluorouracil—colon cancer	0.00016	0.00334	CcSEcCtD
Trimethoprim—Anorexia—Irinotecan—colon cancer	0.000159	0.00332	CcSEcCtD
Trimethoprim—Ataxia—Methotrexate—colon cancer	0.000159	0.00332	CcSEcCtD
Trimethoprim—ABCB1—epithelium—colon cancer	0.000158	0.0153	CbGeAlD
Trimethoprim—Nervous system disorder—Fluorouracil—colon cancer	0.000157	0.00327	CcSEcCtD
Trimethoprim—Thrombocytopenia—Fluorouracil—colon cancer	0.000157	0.00327	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Vincristine—colon cancer	0.000156	0.00326	CcSEcCtD
Trimethoprim—Urinary tract disorder—Capecitabine—colon cancer	0.000155	0.00324	CcSEcCtD
Trimethoprim—Insomnia—Vincristine—colon cancer	0.000155	0.00324	CcSEcCtD
Trimethoprim—Connective tissue disorder—Capecitabine—colon cancer	0.000155	0.00323	CcSEcCtD
Trimethoprim—Urethral disorder—Capecitabine—colon cancer	0.000154	0.00322	CcSEcCtD
Trimethoprim—Anorexia—Fluorouracil—colon cancer	0.000153	0.00318	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000153	0.00318	CcSEcCtD
Trimethoprim—Insomnia—Irinotecan—colon cancer	0.000151	0.00315	CcSEcCtD
Trimethoprim—Decreased appetite—Vincristine—colon cancer	0.000149	0.00311	CcSEcCtD
Trimethoprim—Dyspnoea—Irinotecan—colon cancer	0.000149	0.00311	CcSEcCtD
Trimethoprim—Erythema multiforme—Capecitabine—colon cancer	0.000149	0.0031	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vincristine—colon cancer	0.000148	0.00309	CcSEcCtD
Trimethoprim—Eye disorder—Capecitabine—colon cancer	0.000147	0.00307	CcSEcCtD
Trimethoprim—Dyspepsia—Irinotecan—colon cancer	0.000147	0.00307	CcSEcCtD
Trimethoprim—Tinnitus—Capecitabine—colon cancer	0.000147	0.00306	CcSEcCtD
Trimethoprim—Constipation—Vincristine—colon cancer	0.000147	0.00306	CcSEcCtD
Trimethoprim—ABCB1—renal system—colon cancer	0.000146	0.0142	CbGeAlD
Trimethoprim—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000146	0.00304	CcSEcCtD
Trimethoprim—Decreased appetite—Irinotecan—colon cancer	0.000145	0.00303	CcSEcCtD
Trimethoprim—Eosinophilia—Methotrexate—colon cancer	0.000145	0.00302	CcSEcCtD
Trimethoprim—Insomnia—Fluorouracil—colon cancer	0.000145	0.00302	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Irinotecan—colon cancer	0.000144	0.00301	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000144	0.0139	CbGpPWpGaD
Trimethoprim—Pancreatitis—Methotrexate—colon cancer	0.000144	0.00299	CcSEcCtD
Trimethoprim—Constipation—Irinotecan—colon cancer	0.000143	0.00298	CcSEcCtD
Trimethoprim—Dyspnoea—Fluorouracil—colon cancer	0.000143	0.00298	CcSEcCtD
Trimethoprim—Immune system disorder—Capecitabine—colon cancer	0.000142	0.00297	CcSEcCtD
Trimethoprim—Mediastinal disorder—Capecitabine—colon cancer	0.000142	0.00296	CcSEcCtD
Trimethoprim—Dyspepsia—Fluorouracil—colon cancer	0.000141	0.00294	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Vincristine—colon cancer	0.00014	0.00293	CcSEcCtD
Trimethoprim—Decreased appetite—Fluorouracil—colon cancer	0.000139	0.0029	CcSEcCtD
Trimethoprim—Pancytopenia—Methotrexate—colon cancer	0.000139	0.0029	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000138	0.00288	CcSEcCtD
Trimethoprim—Mental disorder—Capecitabine—colon cancer	0.000138	0.00288	CcSEcCtD
Trimethoprim—Feeling abnormal—Irinotecan—colon cancer	0.000138	0.00287	CcSEcCtD
Trimethoprim—Erythema—Capecitabine—colon cancer	0.000137	0.00286	CcSEcCtD
Trimethoprim—Malnutrition—Capecitabine—colon cancer	0.000137	0.00286	CcSEcCtD
Trimethoprim—Neutropenia—Methotrexate—colon cancer	0.000137	0.00286	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Irinotecan—colon cancer	0.000137	0.00285	CcSEcCtD
Trimethoprim—DHFR—Metabolism of nitric oxide—AKT1—colon cancer	0.000136	0.0131	CbGpPWpGaD
Trimethoprim—Body temperature increased—Vincristine—colon cancer	0.000136	0.00283	CcSEcCtD
Trimethoprim—Abdominal pain—Vincristine—colon cancer	0.000136	0.00283	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Methotrexate—colon cancer	0.000134	0.00279	CcSEcCtD
Trimethoprim—Body temperature increased—Irinotecan—colon cancer	0.000132	0.00276	CcSEcCtD
Trimethoprim—Abdominal pain—Irinotecan—colon cancer	0.000132	0.00276	CcSEcCtD
Trimethoprim—Feeling abnormal—Fluorouracil—colon cancer	0.000132	0.00275	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—colon cancer	0.000131	0.00274	CcSEcCtD
Trimethoprim—Infestation—Methotrexate—colon cancer	0.000131	0.00272	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—colon cancer	0.000131	0.00272	CcSEcCtD
Trimethoprim—Depression—Methotrexate—colon cancer	0.00013	0.00271	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00013	0.0125	CbGpPWpGaD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000129	0.0027	CcSEcCtD
Trimethoprim—Tremor—Capecitabine—colon cancer	0.000128	0.00268	CcSEcCtD
Trimethoprim—Renal failure—Methotrexate—colon cancer	0.000128	0.00268	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—colon cancer	0.000127	0.00265	CcSEcCtD
Trimethoprim—Urticaria—Fluorouracil—colon cancer	0.000127	0.00265	CcSEcCtD
Trimethoprim—Body temperature increased—Fluorouracil—colon cancer	0.000127	0.00264	CcSEcCtD
Trimethoprim—Hypersensitivity—Vincristine—colon cancer	0.000126	0.00264	CcSEcCtD
Trimethoprim—CYP3A4—liver—colon cancer	0.000126	0.0122	CbGeAlD
Trimethoprim—Haematuria—Methotrexate—colon cancer	0.000124	0.0026	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—colon cancer	0.000123	0.00257	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—colon cancer	0.000123	0.00257	CcSEcCtD
Trimethoprim—Vertigo—Capecitabine—colon cancer	0.000123	0.00257	CcSEcCtD
Trimethoprim—Hypersensitivity—Irinotecan—colon cancer	0.000123	0.00257	CcSEcCtD
Trimethoprim—Syncope—Capecitabine—colon cancer	0.000123	0.00256	CcSEcCtD
Trimethoprim—Leukopenia—Capecitabine—colon cancer	0.000123	0.00256	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—colon cancer	0.000122	0.00254	CcSEcCtD
Trimethoprim—ABCB1—lymphoid tissue—colon cancer	0.000122	0.0118	CbGeAlD
Trimethoprim—Loss of consciousness—Capecitabine—colon cancer	0.00012	0.00251	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—TYMS—colon cancer	0.00012	0.0116	CbGpPWpGaD
Trimethoprim—ABCB1—digestive system—colon cancer	0.00012	0.0116	CbGeAlD
Trimethoprim—Cough—Capecitabine—colon cancer	0.00012	0.00249	CcSEcCtD
Trimethoprim—Hypersensitivity—Fluorouracil—colon cancer	0.000118	0.00246	CcSEcCtD
Trimethoprim—Diarrhoea—Vincristine—colon cancer	0.000117	0.00245	CcSEcCtD
Trimethoprim—Myalgia—Capecitabine—colon cancer	0.000117	0.00243	CcSEcCtD
Trimethoprim—Arthralgia—Capecitabine—colon cancer	0.000117	0.00243	CcSEcCtD
Trimethoprim—Anxiety—Capecitabine—colon cancer	0.000116	0.00242	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—MLH3—colon cancer	0.000116	0.0112	CbGpPWpGaD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000116	0.00242	CcSEcCtD
Trimethoprim—Urinary tract disorder—Methotrexate—colon cancer	0.000116	0.00241	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—colon cancer	0.000115	0.0024	CcSEcCtD
Trimethoprim—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000115	0.011	CbGpPWpGaD
Trimethoprim—Diarrhoea—Irinotecan—colon cancer	0.000114	0.00238	CcSEcCtD
Trimethoprim—Dizziness—Vincristine—colon cancer	0.000113	0.00237	CcSEcCtD
Trimethoprim—Pruritus—Fluorouracil—colon cancer	0.000113	0.00236	CcSEcCtD
Trimethoprim—Confusional state—Capecitabine—colon cancer	0.000113	0.00235	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—colon cancer	0.000111	0.00231	CcSEcCtD
Trimethoprim—ABCB1—bone marrow—colon cancer	0.000111	0.0107	CbGeAlD
Trimethoprim—Dizziness—Irinotecan—colon cancer	0.000111	0.0023	CcSEcCtD
Trimethoprim—Shock—Capecitabine—colon cancer	0.00011	0.00229	CcSEcCtD
Trimethoprim—Nervous system disorder—Capecitabine—colon cancer	0.00011	0.00229	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—colon cancer	0.00011	0.00228	CcSEcCtD
Trimethoprim—Diarrhoea—Fluorouracil—colon cancer	0.00011	0.00228	CcSEcCtD
Trimethoprim—Thrombocytopenia—Capecitabine—colon cancer	0.00011	0.00228	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000109	0.0105	CbGpPWpGaD
Trimethoprim—Tinnitus—Methotrexate—colon cancer	0.000109	0.00228	CcSEcCtD
Trimethoprim—Vomiting—Vincristine—colon cancer	0.000109	0.00228	CcSEcCtD
Trimethoprim—Skin disorder—Capecitabine—colon cancer	0.000109	0.00227	CcSEcCtD
Trimethoprim—Rash—Vincristine—colon cancer	0.000108	0.00226	CcSEcCtD
Trimethoprim—Dermatitis—Vincristine—colon cancer	0.000108	0.00225	CcSEcCtD
Trimethoprim—Headache—Vincristine—colon cancer	0.000107	0.00224	CcSEcCtD
Trimethoprim—Anorexia—Capecitabine—colon cancer	0.000107	0.00222	CcSEcCtD
Trimethoprim—Vomiting—Irinotecan—colon cancer	0.000106	0.00222	CcSEcCtD
Trimethoprim—ABCB1—vagina—colon cancer	0.000106	0.0103	CbGeAlD
Trimethoprim—Immune system disorder—Methotrexate—colon cancer	0.000106	0.00221	CcSEcCtD
Trimethoprim—Dizziness—Fluorouracil—colon cancer	0.000106	0.00221	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—colon cancer	0.000106	0.0022	CcSEcCtD
Trimethoprim—Rash—Irinotecan—colon cancer	0.000105	0.0022	CcSEcCtD
Trimethoprim—Dermatitis—Irinotecan—colon cancer	0.000105	0.0022	CcSEcCtD
Trimethoprim—Headache—Irinotecan—colon cancer	0.000105	0.00218	CcSEcCtD
Trimethoprim—DHFR—Fluoropyrimidine Activity—TP53—colon cancer	0.000104	0.01	CbGpPWpGaD
Trimethoprim—Mental disorder—Methotrexate—colon cancer	0.000103	0.00214	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—colon cancer	0.000102	0.00213	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—colon cancer	0.000102	0.00213	CcSEcCtD
Trimethoprim—Nausea—Vincristine—colon cancer	0.000102	0.00213	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000102	0.00213	CcSEcCtD
Trimethoprim—Vomiting—Fluorouracil—colon cancer	0.000102	0.00212	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—TYMS—colon cancer	0.000101	0.00977	CbGpPWpGaD
Trimethoprim—Insomnia—Capecitabine—colon cancer	0.000101	0.00211	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—MLH3—colon cancer	0.000101	0.00974	CbGpPWpGaD
Trimethoprim—Rash—Fluorouracil—colon cancer	0.000101	0.0021	CcSEcCtD
Trimethoprim—Dermatitis—Fluorouracil—colon cancer	0.000101	0.0021	CcSEcCtD
Trimethoprim—Headache—Fluorouracil—colon cancer	0.0001	0.00209	CcSEcCtD
Trimethoprim—Dyspnoea—Capecitabine—colon cancer	9.97e-05	0.00208	CcSEcCtD
Trimethoprim—Nausea—Irinotecan—colon cancer	9.93e-05	0.00207	CcSEcCtD
Trimethoprim—Dyspepsia—Capecitabine—colon cancer	9.85e-05	0.00205	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	9.81e-05	0.00945	CbGpPWpGaD
Trimethoprim—Decreased appetite—Capecitabine—colon cancer	9.72e-05	0.00203	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Capecitabine—colon cancer	9.66e-05	0.00201	CcSEcCtD
Trimethoprim—Constipation—Capecitabine—colon cancer	9.56e-05	0.00199	CcSEcCtD
Trimethoprim—Nausea—Fluorouracil—colon cancer	9.51e-05	0.00198	CcSEcCtD
Trimethoprim—Feeling abnormal—Capecitabine—colon cancer	9.22e-05	0.00192	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—colon cancer	9.17e-05	0.00191	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Capecitabine—colon cancer	9.15e-05	0.00191	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—colon cancer	9.13e-05	0.0019	CcSEcCtD
Trimethoprim—DHFR—Metabolism—CA7—colon cancer	9.09e-05	0.00875	CbGpPWpGaD
Trimethoprim—TYMS—Fluoropyrimidine Activity—TP53—colon cancer	9.06e-05	0.00872	CbGpPWpGaD
Trimethoprim—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	8.99e-05	0.00866	CbGpPWpGaD
Trimethoprim—ABCB1—liver—colon cancer	8.95e-05	0.00867	CbGeAlD
Trimethoprim—Cough—Methotrexate—colon cancer	8.9e-05	0.00186	CcSEcCtD
Trimethoprim—Urticaria—Capecitabine—colon cancer	8.89e-05	0.00185	CcSEcCtD
Trimethoprim—Abdominal pain—Capecitabine—colon cancer	8.84e-05	0.00184	CcSEcCtD
Trimethoprim—Body temperature increased—Capecitabine—colon cancer	8.84e-05	0.00184	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—colon cancer	8.84e-05	0.00184	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	8.75e-05	0.00842	CbGpPWpGaD
Trimethoprim—Myalgia—Methotrexate—colon cancer	8.69e-05	0.00181	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—colon cancer	8.69e-05	0.00181	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	8.63e-05	0.0018	CcSEcCtD
Trimethoprim—Confusional state—Methotrexate—colon cancer	8.4e-05	0.00175	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—colon cancer	8.33e-05	0.00174	CcSEcCtD
Trimethoprim—Hypersensitivity—Capecitabine—colon cancer	8.24e-05	0.00172	CcSEcCtD
Trimethoprim—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	8.22e-05	0.00791	CbGpPWpGaD
Trimethoprim—Nervous system disorder—Methotrexate—colon cancer	8.16e-05	0.0017	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—colon cancer	8.15e-05	0.0017	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—colon cancer	8.09e-05	0.00169	CcSEcCtD
Trimethoprim—DHFR—E2F transcription factor network—CDKN1A—colon cancer	8.08e-05	0.00778	CbGpPWpGaD
Trimethoprim—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	8.03e-05	0.00773	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	7.99e-05	0.00769	CbGpPWpGaD
Trimethoprim—Anorexia—Methotrexate—colon cancer	7.94e-05	0.00166	CcSEcCtD
Trimethoprim—TYMS—Metabolism—CA7—colon cancer	7.93e-05	0.00764	CbGpPWpGaD
Trimethoprim—Pruritus—Capecitabine—colon cancer	7.91e-05	0.00165	CcSEcCtD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	7.9e-05	0.0076	CbGpPWpGaD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.83e-05	0.00754	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—EP300—colon cancer	7.69e-05	0.0074	CbGpPWpGaD
Trimethoprim—Diarrhoea—Capecitabine—colon cancer	7.65e-05	0.0016	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—colon cancer	7.59e-05	0.00158	CcSEcCtD
Trimethoprim—CYP3A4—Irinotecan Pathway—APC—colon cancer	7.57e-05	0.00729	CbGpPWpGaD
Trimethoprim—Insomnia—Methotrexate—colon cancer	7.53e-05	0.00157	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—colon cancer	7.42e-05	0.00155	CcSEcCtD
Trimethoprim—Dizziness—Capecitabine—colon cancer	7.4e-05	0.00154	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—colon cancer	7.33e-05	0.00153	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	7.26e-05	0.00699	CbGpPWpGaD
Trimethoprim—Decreased appetite—Methotrexate—colon cancer	7.24e-05	0.00151	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—colon cancer	7.19e-05	0.0015	CcSEcCtD
Trimethoprim—Vomiting—Capecitabine—colon cancer	7.11e-05	0.00148	CcSEcCtD
Trimethoprim—Rash—Capecitabine—colon cancer	7.05e-05	0.00147	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—CDKN1A—colon cancer	7.05e-05	0.00679	CbGpPWpGaD
Trimethoprim—Dermatitis—Capecitabine—colon cancer	7.05e-05	0.00147	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	7.02e-05	0.00676	CbGpPWpGaD
Trimethoprim—Headache—Capecitabine—colon cancer	7.01e-05	0.00146	CcSEcCtD
Trimethoprim—ABCB1—lymph node—colon cancer	6.86e-05	0.00665	CbGeAlD
Trimethoprim—Feeling abnormal—Methotrexate—colon cancer	6.86e-05	0.00143	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	6.83e-05	0.00657	CbGpPWpGaD
Trimethoprim—Gastrointestinal pain—Methotrexate—colon cancer	6.81e-05	0.00142	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—EP300—colon cancer	6.71e-05	0.00646	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—MYC—colon cancer	6.7e-05	0.00645	CbGpPWpGaD
Trimethoprim—Nausea—Capecitabine—colon cancer	6.64e-05	0.00139	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—colon cancer	6.61e-05	0.00138	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—colon cancer	6.58e-05	0.00137	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—colon cancer	6.58e-05	0.00137	CcSEcCtD
Trimethoprim—DHFR—Disease—LGR5—colon cancer	6.57e-05	0.00633	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CHST5—colon cancer	6.57e-05	0.00633	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	6.46e-05	0.00622	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	6.33e-05	0.0061	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Methotrexate—colon cancer	6.13e-05	0.00128	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	6.13e-05	0.0059	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—TP53—colon cancer	5.96e-05	0.00574	CbGpPWpGaD
Trimethoprim—Pruritus—Methotrexate—colon cancer	5.89e-05	0.00123	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	5.88e-05	0.00566	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—CDKN1A—colon cancer	5.86e-05	0.00565	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—MYC—colon cancer	5.85e-05	0.00563	CbGpPWpGaD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.83e-05	0.00561	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—MYC—colon cancer	5.82e-05	0.00561	CbGpPWpGaD
Trimethoprim—Diarrhoea—Methotrexate—colon cancer	5.7e-05	0.00119	CcSEcCtD
Trimethoprim—DHFR—Metabolism—CHST5—colon cancer	5.51e-05	0.0053	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ODC1—colon cancer	5.51e-05	0.0053	CbGpPWpGaD
Trimethoprim—Dizziness—Methotrexate—colon cancer	5.51e-05	0.00115	CcSEcCtD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.45e-05	0.00524	CbGpPWpGaD
Trimethoprim—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	5.42e-05	0.00522	CbGpPWpGaD
Trimethoprim—Vomiting—Methotrexate—colon cancer	5.29e-05	0.0011	CcSEcCtD
Trimethoprim—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	5.27e-05	0.00507	CbGpPWpGaD
Trimethoprim—Rash—Methotrexate—colon cancer	5.25e-05	0.00109	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—colon cancer	5.24e-05	0.00109	CcSEcCtD
Trimethoprim—Headache—Methotrexate—colon cancer	5.22e-05	0.00109	CcSEcCtD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.16e-05	0.00497	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—CDKN1A—colon cancer	5.12e-05	0.00493	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CCND1—colon cancer	5.11e-05	0.00492	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MLH1—colon cancer	5.1e-05	0.00491	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MYC—colon cancer	5.08e-05	0.00489	CbGpPWpGaD
Trimethoprim—Nausea—Methotrexate—colon cancer	4.95e-05	0.00103	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—CDKN1A—colon cancer	4.94e-05	0.00476	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—APC—colon cancer	4.92e-05	0.00474	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—MYC—colon cancer	4.86e-05	0.00468	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—BUB1B—colon cancer	4.85e-05	0.00467	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CHST5—colon cancer	4.8e-05	0.00463	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ODC1—colon cancer	4.8e-05	0.00463	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—colon cancer	4.78e-05	0.0046	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AXIN2—colon cancer	4.72e-05	0.00455	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—PPARG—colon cancer	4.56e-05	0.00439	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CCND1—colon cancer	4.46e-05	0.00429	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MLH1—colon cancer	4.45e-05	0.00429	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—BUB1B—colon cancer	4.34e-05	0.00418	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—CDKN1A—colon cancer	4.31e-05	0.00415	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—MYC—colon cancer	4.24e-05	0.00408	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—BUB1B—colon cancer	4.23e-05	0.00408	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—colon cancer	4.17e-05	0.00402	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—MYC—colon cancer	4.1e-05	0.00394	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.01e-05	0.00386	CbGpPWpGaD
Trimethoprim—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	3.87e-05	0.00372	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—BUB1B—colon cancer	3.79e-05	0.00365	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.74e-05	0.0036	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—TYMS—colon cancer	3.72e-05	0.00358	CbGpPWpGaD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.59e-05	0.00346	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—MYC—colon cancer	3.57e-05	0.00344	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.47e-05	0.00334	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3.38e-05	0.00325	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.38e-05	0.00325	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	3.34e-05	0.00322	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TYMS—colon cancer	3.33e-05	0.0032	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.27e-05	0.00314	CbGpPWpGaD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	3.15e-05	0.00303	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.11e-05	0.00299	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	3.02e-05	0.00291	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—EP300—colon cancer	2.98e-05	0.00287	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.94e-05	0.00283	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA7—colon cancer	2.81e-05	0.0027	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.71e-05	0.00261	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.7e-05	0.0026	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.7e-05	0.0026	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.65e-05	0.00255	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.5e-05	0.00241	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.48e-05	0.00239	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA7—colon cancer	2.45e-05	0.00236	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.3e-05	0.00221	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA7—colon cancer	2.29e-05	0.0022	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.24e-05	0.00216	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.22e-05	0.00214	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CASP3—colon cancer	2.17e-05	0.00209	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—colon cancer	2.13e-05	0.00206	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.13e-05	0.00205	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.07e-05	0.00199	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.99e-05	0.00192	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.88e-05	0.00181	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—colon cancer	1.87e-05	0.0018	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.84e-05	0.00177	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.81e-05	0.00174	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—EP300—colon cancer	1.72e-05	0.00166	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ODC1—colon cancer	1.7e-05	0.00164	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CHST5—colon cancer	1.7e-05	0.00164	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.69e-05	0.00163	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND1—colon cancer	1.67e-05	0.00161	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—colon cancer	1.63e-05	0.00157	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1A—colon cancer	1.62e-05	0.00156	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.58e-05	0.00152	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—EP300—colon cancer	1.54e-05	0.00148	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.52e-05	0.00146	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA7—colon cancer	1.51e-05	0.00145	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—EP300—colon cancer	1.5e-05	0.00145	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—colon cancer	1.5e-05	0.00145	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CHST5—colon cancer	1.48e-05	0.00143	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ODC1—colon cancer	1.48e-05	0.00143	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—colon cancer	1.46e-05	0.00141	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ABCB1—colon cancer	1.46e-05	0.0014	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—TYMS—colon cancer	1.43e-05	0.00138	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1A—colon cancer	1.41e-05	0.00136	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ODC1—colon cancer	1.38e-05	0.00133	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CHST5—colon cancer	1.38e-05	0.00133	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGFR3—colon cancer	1.36e-05	0.00131	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.36e-05	0.00131	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—EP300—colon cancer	1.35e-05	0.0013	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—colon cancer	1.34e-05	0.00129	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—colon cancer	1.31e-05	0.00126	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ABCB1—colon cancer	1.27e-05	0.00122	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APC—colon cancer	1.25e-05	0.00121	CbGpPWpGaD
Trimethoprim—DHFR—Disease—BRAF—colon cancer	1.18e-05	0.00113	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—colon cancer	1.17e-05	0.00113	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.15e-05	0.00111	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—colon cancer	1.1e-05	0.00106	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.07e-05	0.00103	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.04e-05	0.001	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.03e-05	0.000993	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPARG—colon cancer	1.01e-05	0.000975	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.01e-05	0.00097	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—colon cancer	9.63e-06	0.000927	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	9.59e-06	0.000923	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—colon cancer	9.51e-06	0.000916	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	9.32e-06	0.000898	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ODC1—colon cancer	9.13e-06	0.000879	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CHST5—colon cancer	9.13e-06	0.000879	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	9.08e-06	0.000874	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARG—colon cancer	8.83e-06	0.000851	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—colon cancer	8.51e-06	0.000819	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	8.36e-06	0.000805	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	8.34e-06	0.000803	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1A—colon cancer	8.31e-06	0.0008	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	8.17e-06	0.000787	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—colon cancer	7.96e-06	0.000767	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EP300—colon cancer	7.91e-06	0.000761	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.72e-06	0.000743	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SRC—colon cancer	7.69e-06	0.00074	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NRAS—colon cancer	7.4e-06	0.000712	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	7.09e-06	0.000683	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.02e-06	0.000676	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—colon cancer	6.95e-06	0.000669	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—colon cancer	6.89e-06	0.000664	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—colon cancer	6.87e-06	0.000662	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.86e-06	0.000661	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—colon cancer	6.74e-06	0.000649	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—EP300—colon cancer	6.62e-06	0.000638	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—colon cancer	6.37e-06	0.000613	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—colon cancer	5.85e-06	0.000563	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.79e-06	0.000558	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—EP300—colon cancer	5.78e-06	0.000556	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.72e-06	0.000551	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.53e-06	0.000532	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—colon cancer	5.41e-06	0.000521	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—colon cancer	4.9e-06	0.000472	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—colon cancer	4.78e-06	0.00046	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.6e-06	0.000443	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.5e-06	0.000433	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—colon cancer	4.5e-06	0.000433	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TYMS—colon cancer	4.42e-06	0.000425	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—colon cancer	4.28e-06	0.000412	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—colon cancer	4e-06	0.000385	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TYMS—colon cancer	3.85e-06	0.00037	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.74e-06	0.00036	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—colon cancer	3.66e-06	0.000352	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TYMS—colon cancer	3.59e-06	0.000346	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—colon cancer	3.49e-06	0.000336	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.4e-06	0.000327	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARG—colon cancer	3.13e-06	0.000301	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.77e-06	0.000266	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARG—colon cancer	2.73e-06	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARG—colon cancer	2.55e-06	0.000245	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—colon cancer	2.46e-06	0.000237	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—colon cancer	2.41e-06	0.000232	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TYMS—colon cancer	2.37e-06	0.000228	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—colon cancer	2.14e-06	0.000206	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—EP300—colon cancer	2.05e-06	0.000197	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—colon cancer	2e-06	0.000193	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—EP300—colon cancer	1.78e-06	0.000172	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARG—colon cancer	1.68e-06	0.000162	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—EP300—colon cancer	1.67e-06	0.00016	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—colon cancer	1.51e-06	0.000146	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—colon cancer	1.32e-06	0.000127	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—colon cancer	1.32e-06	0.000127	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—colon cancer	1.24e-06	0.000119	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—colon cancer	1.23e-06	0.000119	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—EP300—colon cancer	1.1e-06	0.000106	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—colon cancer	1.08e-06	0.000104	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—colon cancer	1.01e-06	9.69e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—colon cancer	8.13e-07	7.83e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—colon cancer	6.64e-07	6.39e-05	CbGpPWpGaD
